1148584

Marlex Pharmaceuticals, Inc. — FEI 1000121454

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 12, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New Castle, DE (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673021 CFR 314.80(b)Failure to develop written procedures